Recerca > Càncer

Grup de recerca de biomarcadors en càncer (GReBiC)

Nombre de publicacions
495
Cercador de publicacions

  • Porcel, Jose M.; Azzopardi, M.; Koegelenberg, C. F.; Maldonado, F.; Rahman, N. M.; Lee, Y. C. G.

    The diagnosis of pleural effusions

    EXPERT REVIEW OF RESPIRATORY MEDICINE 9 801-815. .

    [doi:10.1586/17476348.2015.1098535]

  • Llombart-Cussac A; Bermejo B; Villanueva C; Delaloge S; Morales S; Balmaña J; Amillano K; Bonnefoi H; Casas A; Manso L; Roché H; Gonzalez-Santiago S; Gavilá J; Sánchez-Rovira P; Di Cosimo S; Harbeck N; Charpentier E; Garcia-Ribas I; Radosevic-Robin N; Aura C; Baselga J

    SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer

    BREAST CANCER RESEARCH AND TREATMENT 154 351-357. .

    [doi:10.1007/s10549-015-3616-8]

  • Cuadrat I; Bielsa S; Pardina M; Porcel JM

    Septic thrombophlebitis caused by viridans group Streptococci

    REVISTA CLINICA ESPANOLA 215 474-475. .

    [doi:10.1016/j.rce.2015.03.004]

  • Fernandez-Martos C; Garcia-Albeniz X; Pericay C; Maurel J; Aparicio J; Montagut C; Safont MJ; Salud A; Vera R; Massuti B; Escudero P; Alonso V; Bosch C; Martin M; Minsky BD

    Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial

    ANNALS OF ONCOLOGY 26 1722-1728. .

    [doi:10.1093/annonc/mdv223]

  • Porcel JM

    Distinguishing complicated from uncomplicated parapneumonic effusions

    Current Opinion in Pulmonary Medicine 21 346-351. .

    [doi:10.1097/MCP.0000000000000164]

  • Porcel JM; Palma R; Bielsa S; Esquerda A; Gatius S; Matias-Guiu X; Salud A

    TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions

    RESPIROLOGY 20 831-833. .

    [doi:10.1111/resp.12543]

  • Fysh ET; Bielsa S; Budgeon CA; Read CA; Porcel JM; Maskell NA; Lee YC

    Predictors of Clinical Use of Pleurodesis and/or Indwelling Pleural Catheter Therapy for Malignant Pleural Effusion

    Chest 147 1629-1634. .

    [doi:10.1378/chest.14-1701]

  • Martín M; González-Rivera M; Morales S; de la Haba-Rodriguez J; González-Cortijo L; Manso L; Albanell J; González-Martín A; González S; Arcusa A; de la Cruz-Merino L; Rojo F; Vidal M; Galván P; Aguirre E; Morales C; Ferree S; Pompilio K; Casas M; Caballero R; Goicoechea U; Carrasco E; Michalopoulos S; Hornberger J; Prat A

    Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer

    Current Medical Research and Opinion 31 1129-1137. .

    [doi:10.1185/03007995.2015.1037730]

  • Porcel JM; Statophoulos G; Lee YC

    Advances and controversies in pleural diseases

    Journal of Thoracic Disease 7 961-963. .

    [doi:10.3978/j.issn.2072-1439.2015.04.29]

  • Gil-Gil, M.J.; Bellet, M.; Morales, S.; Ojeda, B.; Manso, L.; Mesia, C.; Garcia-Martínez, E.; Martinez-Jáñez, N.; Melé, M.; Llombart, A.; Pernas, S.; Villagrasa, P.; Blasco, C.; Baselga, J.

    Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study

    BREAST CANCER RESEARCH AND TREATMENT 151 597-606. .

    [doi:10.1007/s10549-015-3415-2]

  • Porcel JM; Gasol A; Bielsa S; Civit C; Light RW; Salud A

    Clinical features and survival of lung cancer patients with pleural effusions

    RESPIROLOGY 20 654-659. .

    [doi:10.1111/resp.12496]

  • Takahashi K; Porcel JM; Lee P; Leung CC

    Year in review 2014: Lung cancer, pleural diseases, respiratory infections and tuberculosis, bronchoscopic intervention and imaging

    RESPIROLOGY 20 674-683. .

    [doi:10.1111/resp.12502]